TY - JOUR
T1 - Interleukin 2 receptor α chain gene polymorphisms and risks of multiple sclerosis and neuromyelitis optica in southern Japanese
AU - Ainiding, Gulibahaer
AU - Kawano, Yuji
AU - Sato, Shinya
AU - Isobe, Noriko
AU - Matsushita, Takuya
AU - Yoshimura, Satoshi
AU - Yonekawa, Tomomi
AU - Yamasaki, Ryo
AU - Murai, Hiroyuki
AU - Kira, Jun Ichi
N1 - Funding Information:
This work was supported in part by a Health and Labour Sciences Research Grant on Intractable Diseases ( H20-Nanchi-Ippan-016 ) from the Ministry of Health, Labour and Welfare, Japan , and a Grant-in-Aid (B; no. 22390178 ) from the Ministry of Education, Culture, Sports, Science and Technology, Japan .
Funding Information:
Dr. Huang, Dr. Yoshimura, Dr. Yonekawa, Dr. Sato, and Dr. Yamasaki report no disclosures. Dr. Isobe received a postdoctoral fellowship from the Uehara Memorial Foundation . Dr. Matsushita received a grant and payment for manuscript preparation and development of educational presentations from Bayer Schering Pharma , and also receives payment for the development of educational presentations from Mitsubishi Tanabe Pharma . Dr. Kira is an advisory board member for Merck Serono and a consultant for Biogen Idec Japan. He received payment for lectures from Bayer Schering Pharma, Cosmic Cooperation , and Biogen Idec Japan .
PY - 2014/2/15
Y1 - 2014/2/15
N2 - Background Interleukin 2 receptor α subunit (IL2RA) is a genetic risk for multiple sclerosis (MS) in Caucasians. However, the association between MS and IL2RA in Japanese idiopathic demyelinating diseases of the central nervous system has not been examined. Objective To determine whether IL2RA gene polymorphisms confer risks of developing MS or neuromyelitis optica (NMO) in a Japanese population. Methods DNA samples were obtained from 115 MS patients, 75 NMO/NMO spectrum disorder (NMOSD) patients, and 238 healthy controls. The single nucleotide polymorphisms (SNPs) rs2104286, rs12722489, and rs7090512 were genotyped by real-time PCR using TaqMan SNP genotyping assays. Results No significant associations of the three IL2RA SNPs with the development of the diseases were observed. In MS patients only, the annualized relapse rates were significantly higher for the rs2104286-TT genotype than for the non-TT (CT+CC) genotype and for the rs12722489-CC genotype than for the non-CC genotype in females (p = 0.0138 for both), but not in males. Conclusions Although the possibility that IL2RA is a risk factor for MS development was not confirmed in this Japanese population, IL2RA gene polymorphisms were able to modify the disease activity in female MS patients, but had no influence on either susceptibility or disease phenotype in NMO/NMOSD patients.
AB - Background Interleukin 2 receptor α subunit (IL2RA) is a genetic risk for multiple sclerosis (MS) in Caucasians. However, the association between MS and IL2RA in Japanese idiopathic demyelinating diseases of the central nervous system has not been examined. Objective To determine whether IL2RA gene polymorphisms confer risks of developing MS or neuromyelitis optica (NMO) in a Japanese population. Methods DNA samples were obtained from 115 MS patients, 75 NMO/NMO spectrum disorder (NMOSD) patients, and 238 healthy controls. The single nucleotide polymorphisms (SNPs) rs2104286, rs12722489, and rs7090512 were genotyped by real-time PCR using TaqMan SNP genotyping assays. Results No significant associations of the three IL2RA SNPs with the development of the diseases were observed. In MS patients only, the annualized relapse rates were significantly higher for the rs2104286-TT genotype than for the non-TT (CT+CC) genotype and for the rs12722489-CC genotype than for the non-CC genotype in females (p = 0.0138 for both), but not in males. Conclusions Although the possibility that IL2RA is a risk factor for MS development was not confirmed in this Japanese population, IL2RA gene polymorphisms were able to modify the disease activity in female MS patients, but had no influence on either susceptibility or disease phenotype in NMO/NMOSD patients.
UR - http://www.scopus.com/inward/record.url?scp=84894090466&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84894090466&partnerID=8YFLogxK
U2 - 10.1016/j.jns.2013.11.037
DO - 10.1016/j.jns.2013.11.037
M3 - Article
C2 - 24332945
AN - SCOPUS:84894090466
SN - 0022-510X
VL - 337
SP - 147
EP - 150
JO - Journal of the Neurological Sciences
JF - Journal of the Neurological Sciences
IS - 1-2
ER -